Deleted Tweets From Scott Gottlieb, R-D.C.

As part of #FDA’s goal of encouraging appropriate prescribing/use of all opioid products, we’re committed to an open discussion about how the REMS programs are working. Upcoming TIRF REMS advisory committee meeting is part of that work: https://t.co/RSCEMysENz

More must be done to facilitate treatment options & development of therapies to address opioid use disorder as a chronic disease by 1) helping more people secure medication-assisted treatment and 2) finding new/more effective ways to advance use of medical therapy. #stopMATstigma https://t.co/UbcUD5uJVt

3/6 French FDP is authorized to treat U.S. military personnel with severe or life-threatening hemorrhage due to traumatic injuries sustained in the conduct of military operations in situations when plasma is not available, or when its use is not practical.

THREAD 1/6 At the request of @DeptofDefense, FDA issued an Emergency Use Authorization (EUA) for a freeze dried plasma product (referred to as French FDP). https://t.co/Gii2ik3Up4 https://t.co/0nzMlWja9O

2/6 French FDP is a powdered freeze dried plasma product that can be used following reconstitution in settings where refrigeration is not available, enabling the rapid availability of plasma for use at the point of injury.

4/6 Earlier this year, we reaffirmed our commitment to DoD and the dedicated men and women protecting our country by expediting development and availability of safe, effective, priority medical products essential to health of our military service members. https://t.co/3dNqzvkbAF

6/6 This EUA action is the result of close collaboration between the FDA and the @DeptofDefense to prioritize the efficient development of safe and effective medical products intended to help save the lives of American military personnel. https://t.co/4LeyPxra3x

5/6 Emergency Use Authorization allows FDA to help strengthen the Nation’s public health protections by facilitating availability and use of medical countermeasures needed during public health and military emergencies https://t.co/ulBRXpI8FN  (EUA process graphic attached) https://t.co/rivEi3mHan

RT @SeanKhozin: Quality #RealWorldEvidence can give us “a deeper understanding of a medical product’s safety and benefits, its additional t… QT @SGottliebFDA: My Blog: By expanding use of real world data, #FDA can enhance benefits of traditional clinical trials by eliminati… https://t.co/w3A02BGKf2)

RT @FDASpox: Just announced: @US_FDA is holding an advisory committee mtg on 8/3 to discuss the transmucosal immediate-release f… https://t.co/XgP8rPBlXj

As I talked about in my #TWEETORIAL on expedited development and review pathways, gathering real world data outcomes data is critical to these approaches https://t.co/JIU6B9VXBy QT @SGottliebFDA: A new #FDA Series! Sunday TWEETORIALS! This one an overview of #FDA’s expedited development and review pathways, an… https://t.co/KVXdU2wzrK)

RT @ZacharyBrennan: here're the links to the 6 new draft guidances on gene therapy out this morn and brief rundowns of each one https://t.co/ZMFrXAZODk

RT @FDAMedia: FDA updates warnings for fluoroquinolone antibiotics on risks of mental health and low blood sugar adverse reactions https://t.co/qGyrn4MCZ9

RT @FDATobacco: FDA is seeking information related to the role that flavors, including menthol, play in tobacco products. Share y… https://t.co/yPFlexLzUF

RT @FDAMedia: Statement from FDA Commissioner Scott Gottlieb, M.D. on agency’s efforts to advance development of gene therapies https://t.co/fu8wChmu23

RT @califf001: FDA continues to lead the way in pushing the ecosystem to use evidence generated in clinical care. @DukeForge #FDA https://… QT @SeanKhozin: Quality #RealWorldEvidence can give us “a deeper understanding of a medical product’s safety and benefits, its addi… https://t.co/zqb3cgkSm6)

RT @DoDHealth: Thank you, @SGottliebFDA and @US_FDA. This decision will significantly improve the ability of military medical personnel to… QT @SGottliebFDA: THREAD 1/6 At the request of @DeptofDefense, FDA issued an Emergency Use Authorization (EUA) for a freeze dried pla… https://t.co/fCCeg9ILEE)

#FDA published a summary of our recent workshop that encouraged an inclusion of more diverse clinical trial populations https://t.co/GvNDV0H1tF

RT @FDAfood: How can we better evaluate qualified health claims & statements on food? Become part of the conversation at the FDA… https://t.co/Crq3KLDCYu

Today #FDA issued three new draft guidance documents on development of gene therapy products for specific disease categories and these are the first disease-specific guidances that FDA is issuing for gene therapy products. https://t.co/wjzdgtRfgU

As part of #FDA’s goal of encouraging appropriate prescribing/use of all opioid products, we’re committed to an open discussion about how the REMS programs are working. Upcoming TIRF REMS advisory committee meeting is part of that work: https://t.co/RSCEMysENz

More must be done to facilitate treatment options & development of therapies to address opioid use disorder as a chronic disease by 1) helping more people secure medication-assisted treatment and 2) finding new/more effective ways to advance use of medical therapy. #stopMATstigma https://t.co/UbcUD5uJVt

3/6 French FDP is authorized to treat U.S. military personnel with severe or life-threatening hemorrhage due to traumatic injuries sustained in the conduct of military operations in situations when plasma is not available, or when its use is not practical.

THREAD 1/6 At the request of @DeptofDefense, FDA issued an Emergency Use Authorization (EUA) for a freeze dried plasma product (referred to as French FDP). https://t.co/Gii2ik3Up4 https://t.co/0nzMlWja9O

2/6 French FDP is a powdered freeze dried plasma product that can be used following reconstitution in settings where refrigeration is not available, enabling the rapid availability of plasma for use at the point of injury.

4/6 Earlier this year, we reaffirmed our commitment to DoD and the dedicated men and women protecting our country by expediting development and availability of safe, effective, priority medical products essential to health of our military service members. https://t.co/3dNqzvkbAF

6/6 This EUA action is the result of close collaboration between the FDA and the @DeptofDefense to prioritize the efficient development of safe and effective medical products intended to help save the lives of American military personnel. https://t.co/4LeyPxra3x

5/6 Emergency Use Authorization allows FDA to help strengthen the Nation’s public health protections by facilitating availability and use of medical countermeasures needed during public health and military emergencies https://t.co/ulBRXpI8FN  (EUA process graphic attached) https://t.co/rivEi3mHan

RT @SeanKhozin: Quality #RealWorldEvidence can give us “a deeper understanding of a medical product’s safety and benefits, its additional t… QT @SGottliebFDA: My Blog: By expanding use of real world data, #FDA can enhance benefits of traditional clinical trials by eliminati… https://t.co/w3A02BGKf2)

RT @FDASpox: Just announced: @US_FDA is holding an advisory committee mtg on 8/3 to discuss the transmucosal immediate-release f… https://t.co/XgP8rPBlXj

As I talked about in my #TWEETORIAL on expedited development and review pathways, gathering real world data outcomes data is critical to these approaches https://t.co/JIU6B9VXBy QT @SGottliebFDA: A new #FDA Series! Sunday TWEETORIALS! This one an overview of #FDA’s expedited development and review pathways, an… https://t.co/KVXdU2wzrK)

RT @ZacharyBrennan: here're the links to the 6 new draft guidances on gene therapy out this morn and brief rundowns of each one https://t.co/ZMFrXAZODk

RT @FDAMedia: FDA updates warnings for fluoroquinolone antibiotics on risks of mental health and low blood sugar adverse reactions https://t.co/qGyrn4MCZ9

RT @FDATobacco: FDA is seeking information related to the role that flavors, including menthol, play in tobacco products. Share y… https://t.co/yPFlexLzUF

RT @FDAMedia: Statement from FDA Commissioner Scott Gottlieb, M.D. on agency’s efforts to advance development of gene therapies https://t.co/fu8wChmu23

RT @califf001: FDA continues to lead the way in pushing the ecosystem to use evidence generated in clinical care. @DukeForge #FDA https://… QT @SeanKhozin: Quality #RealWorldEvidence can give us “a deeper understanding of a medical product’s safety and benefits, its addi… https://t.co/zqb3cgkSm6)

RT @DoDHealth: Thank you, @SGottliebFDA and @US_FDA. This decision will significantly improve the ability of military medical personnel to… QT @SGottliebFDA: THREAD 1/6 At the request of @DeptofDefense, FDA issued an Emergency Use Authorization (EUA) for a freeze dried pla… https://t.co/fCCeg9ILEE)

#FDA published a summary of our recent workshop that encouraged an inclusion of more diverse clinical trial populations https://t.co/GvNDV0H1tF

RT @FDAfood: How can we better evaluate qualified health claims & statements on food? Become part of the conversation at the FDA… https://t.co/Crq3KLDCYu

Today #FDA issued three new draft guidance documents on development of gene therapy products for specific disease categories and these are the first disease-specific guidances that FDA is issuing for gene therapy products. https://t.co/wjzdgtRfgU